SG Americas Securities’s ResMed RMD Stock Holding History

SG Americas Securities’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-18,300	Closed	-$6K	–	3182
2021 Q1	$6K	Buy	+18,300	New	+$3.67M	﹤0.01%	3219

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SG Americas Securities's RMD Position: Q2 2026 in Review

SG Americas Securities increased its ResMed (RMD) stake by 111% in Q2 2026, buying an estimated $22.4M and bringing the position to 205,147 shares worth $40M. The position accounts for 0.02% of the portfolio, ranked #400.

SG Americas Securities first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

SG Americas Securities held 205,147 shares of ResMed worth $40M as of Q2 2026.
SG Americas Securities bought 107,872 ResMed shares in Q2 2026, an estimated $22.4M.
ResMed made up 0.02% of SG Americas Securities's portfolio in Q2 2026, its #400 holding.
SG Americas Securities first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.